FWL Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

FWL Investment Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.2K	Hold	72	–	–	﹤0.01%	258
2025 Q4	$8.78K	Hold	72	–	–	﹤0.01%	283
2025 Q3	$7.21K	Hold	72	–	–	﹤0.01%	275
2025 Q2	$5.97K	Sell	72 -23	-24%	-$1.83K	﹤0.01%	258
2025 Q1	$7.71K	Sell	95 -6,418	-99%	-$574K	﹤0.01%	237
2024 Q4	$587K	Sell	6,513 -114,005	-95%	-$11M	0.21%	58
2024 Q3	$11.9M	Buy	120,518 +15,014	+14%	+$1.48M	4.56%	4
2024 Q2	$9.78M	Buy	105,504 +54,644	+107%	+$4.9M	4.93%	5
2024 Q1	$4.83M	Buy	50,860 +50,856	+1,271,400%	+$4.72M	2.66%	16
2023 Q4	$357	Sell	4 -191	-98%	-$14.2K	﹤0.01%	222
2023 Q3	$14.2K	Buy	+195	New	+$15.6K	0.01%	138

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

FWL Investment Management's XBI Position: Q1 2026 in Review

FWL Investment Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 72 shares worth $9.2K. The position accounts for ﹤0.01% of the portfolio, ranked #258.

FWL Investment Management first reported a position in XBI in Q3 2023 and has held it in 11 quarters since. The position peaked at $11.9M in Q3 2024. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

FWL Investment Management held 72 shares of State Street SPDR S&P Biotech ETF worth $9.2K as of Q1 2026.
FWL Investment Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of FWL Investment Management's portfolio in Q1 2026, its #258 holding.
FWL Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2023 and has held it in 11 quarters since.
FWL Investment Management's State Street SPDR S&P Biotech ETF position peaked at $11.9M in Q3 2024.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on FWL Investment Management's 13F filing for Q1 2026, filed 15 May 2026.